MedTrace Logo

A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients

NCT01314625 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2012-05-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether the orthostatic hypotension reported among subjects during bortezomib-containing regimen is caused by a dysfunction of the autonomic nervous system (ANS).

Conditions

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Elias Anaissie, MD · Principal Investigator

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-06-30
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01314625 on ClinicalTrials.gov